Zenlabs Ethica Ltd Stock Price Today (NSE: ZENLABS)

Zenlabs Ethica Ltd

28.83+0.00 (+0.00%)
Market Closed

Fundamental Score

...

Zenlabs Ethica Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Zenlabs Ethica Ltd share price today is 28.83, up +0.00% on NSE/BSE as of 31 July 2026. Zenlabs Ethica Ltd (ZENLABS) is a Small-cap company in the Diversified Commercial Services sector with a market capitalisation of 20.67 (Cr). The 52-week high for ZENLABS share price is 36.82 and the 52-week low is 16.50. At a P/E ratio of 1033.48x, ZENLABS is currently trading above its industry average P/E of 19.79x. The company has a Return on Equity (ROE) of 0.21% and a debt-to-equity ratio of 1.29.

Zenlabs Ethica Ltd Share Price Chart — NSE/BSE Historical Performance

No data
High
28.97
Low
20.20
Volume
14.5K
Change
+26.61%

Zenlabs Ethica Ltd share price chart: 26.61% return over the past month. 52-week high ₹36.82, 52-week low ₹16.50.

Zenlabs Ethica Ltd — Last 10 Trading Days

DateOpenHighLowCloseVolume
24.3928.9724.1028.8366.84K (Cr)
26.0026.0024.1124.392.12K (Cr)
26.0126.3824.1125.2210.10K (Cr)
24.0027.4022.4826.4956.16K (Cr)
22.5224.0222.5223.421.42K (Cr)
23.9923.9922.1123.69925.00 (Cr)
23.4523.4522.0122.90124.00 (Cr)
23.4823.4822.0022.99544.00 (Cr)
24.7624.7622.4522.7317.45K (Cr)
21.4824.9121.4823.9938.42K (Cr)

Zenlabs Ethica Ltd — Last 12 Months Price History

MonthOpenHighLowCloseChange
23.9928.9722.1128.83+20.18%
17.3725.0017.2522.90+31.84%
21.0523.4016.5017.37-17.48%
19.0421.9818.0320.98+10.19%
21.6523.5318.0119.61-9.42%
28.5129.9918.5019.90-30.20%
31.0034.0027.7028.78-7.16%
32.0033.4828.0029.92-6.50%
31.2935.1029.5029.53-5.62%
35.9036.8228.5130.61-14.74%

Returns & Performance

Poor

Return on Equity (ROE)

0.21%

Profit generated per ₹1 of shareholder equity

Poor

Return on Capital (ROCE)

5.07%

Returns generated on total capital deployed

Poor

Oper. Profit Margin (5Y Avg)

4.12%

Average operating profit margin over 5 years

Dividend Yield

0.00%

Annual dividend as % of current share price

Zenlabs Ethica Ltd Valuation Check

Poor

Price to Earnings (P/E)

1033.48x

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

19.79x

Average P/E of all peers in this sector

Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Shareholding Pattern

Excellent

Promoter Holding

52.96%

% shares held by company founders/management

Poor

FII Holding

0.00%

% shares held by foreign institutional investors

Poor

DII Holding

0.00%

% held by domestic mutual funds, LIC, banks

Excellent

Promoter Pledged %

0.00%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Poor

Profit Growth (Quarterly YoY)

-100.00%

Net profit growth vs same quarter last year

Poor

Revenue Growth (Quarterly YoY)

-18.55%

Revenue growth vs same quarter last year

Poor

Revenue Growth (5-Year CAGR)

-3.70%

Compounded annual revenue growth over 5 years

Poor

EPS Growth (5-Year CAGR)

-51.94%

Earnings per share growth over 5 years

Poor

Net Profit Growth (5-Year CAGR)

-51.94%

Compounded annual net profit growth over 5 years

Balance Sheet Health

Poor

Debt to Equity Ratio

1.29x

Total debt ÷ equity. Below 0.5 = financially healthy

Poor

Interest Coverage Ratio

1.33x

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

-1.50 (Cr)

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Zenlabs Ethica Ltd Fundamental Analysis & Valuation Benchmarking

Educational evaluation of ZENLABS across key market metrics for learning purposes.

Positive Indicators

2 factors identified

Balanced Promoter Holding (52.96%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

13 factors identified

Below-Average Return on Equity (0.21%)

Observation: Returns on equity are below industry benchmarks.

Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.

Suboptimal ROCE (5.07%)

Observation: Returns on capital employed are below expectations.

Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.

Margin Pressure Concerns (4.12%)

Observation: Operating margins are below industry standards.

Analysis: OPM <5% may indicate pricing pressures or cost management challenges.

Premium Valuation Risk (P/E: 1033.48x)

Observation: High valuation multiples may limit upside potential.

Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.

Profit Decline Concern (-100.00%)

Observation: Significant year-over-year profit contraction observed.

Analysis: Declining profitability requires investigation into underlying causes.

Revenue Contraction (-18.55%)

Observation: Sales decline may indicate market challenges or competitive pressures.

Analysis: Negative revenue growth requires analysis of market conditions.

Limited Growth History (-3.70% CAGR)

Observation: Below-average 5-year sales growth trajectory.

Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities.

Weak Earnings Growth (-51.94% CAGR)

Observation: Below-average 5-year EPS growth performance.

Analysis: Low EPS growth may not keep pace with inflation.

Stagnant Profit Growth (-51.94% CAGR)

Observation: Limited 5-year profit growth trajectory.

Analysis: Low profit growth may indicate scalability challenges or market maturity.

Elevated Debt Levels (D/E: 1.29)

Observation: High leverage increases financial risk and interest burden.

Analysis: High debt-to-equity ratios require monitoring of debt servicing capability.

Weak Interest Coverage (1.33x)

Observation: Limited ability to service debt obligations from earnings.

Analysis: Low interest coverage raises concerns about financial stability.

Negative Free Cash Flow (₹-1.50 Cr over 5Y)

Observation: Cash outflows exceed inflows.

Analysis: Negative FCF requires analysis of capital expenditure cycle.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.

Zenlabs Ethica Ltd vs Diversified Commercial Services Peers

Peer Comparison - Diversified Commercial Services

Compare Zenlabs Ethica Ltd with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
4.6/100
29
₹20.67
1033.5
Average
0.21%
Poor
5.07%
Poor
1.3
Average
-51.94%
Poor
-3.70%
Poor
0.00%
72.2/100
353
₹15268.32
26.2
Average
23.22%
Excellent
30.72%
Excellent
0.0
Excellent
67.78%
Excellent
48.99%
Excellent
0.71%
Nesco Ltd...
NESCO505355
68.3/100
1065
₹7688.93
18.4
Average
14.84%
Average
18.54%
Good
0.1
Excellent
19.33%
Excellent
26.21%
Excellent
0.64%
61/100
16
₹7318.76
22.6
Average
23.06%
Excellent
16.17%
Good
0.1
Excellent
36.58%
Excellent
37.68%
Excellent
0.00%
10.1/100
135
₹6185.81
65.4
Average
2.47%
Poor
5.08%
Poor
0.6
Good
5.66%
Nirlon Ltd...
NIRLON500307
63.3/100
619
₹5787.56
16.7
Average
83.82%
Excellent
30.77%
Excellent
2.5
Poor
22.12%
Excellent
16.12%
Excellent
4.04%
55.7/100
471
₹5287.73
502.2
Average
3.30%
Poor
8.30%
Poor
9.0
Poor
17.02%
Excellent
45.06%
Excellent
0.00%
39.7/100
264
₹4465.92
14.4
Average
13.20%
Average
17.65%
Good
0.1
Excellent
13.06%
Good
13.75%
Good
2.41%
53.2/100
333
₹4382.22
19.1
Average
20.38%
Excellent
23.04%
Excellent
0.1
Excellent
37.55%
Excellent
7.15%
Good
3.41%
11.3/100
134
₹3892.82
-2.70%
Poor
-1.14%
Poor
0.2
Excellent
-13.16%
Poor
0.00%
64/100
410
₹3761.22
19.8
Average
15.49%
Good
16.68%
Good
0.5
Good
59.97%
Excellent
36.76%
Excellent
0.46%

Zenlabs Ethica Ltd PE Ratio History

Historical price-to-earnings ratio for ZENLABS — last 5 years

YearEPS (₹)Price (₹)P/E Ratio
FY 20240.65₹39.2760.4x

P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.

Zenlabs Ethica Ltd Dividend History

Annual cash dividends paid by ZENLABS — dividend yield N/A

Financial YearDividends Paid (₹ Cr)
FY 20230.16 Cr

Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.

Zenlabs Ethica Ltd Quarterly Performance

Latest quarterly metrics for ZENLABS — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

-18.55%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

-100.00%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

-3.70%

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

-51.94%

Compounded annual net profit growth over 5 years

Zenlabs Ethica Ltd Technical Indicators

SMA 50, SMA 200, RSI and volume signals for ZENLABS — calculated from daily price history

67RSI 14
Neutral — RSI 67

Momentum is balanced — neither overbought nor oversold.

SMA 50
21
▲ Price above SMA 50 — Short-term bullish
SMA 200
26
▲ Price above SMA 200 — Long-term uptrend
30-Day Avg Volume
14K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

Zenlabs Ethica Ltd Financial Statements

Annual income statement, balance sheet and cash flow for Zenlabs Ethica Ltd (ZENLABS) — sourced from NSE/BSE filings.

Loading Financial Statements...

Fetching financial data for Zenlabs Ethica Ltd

About ZENLABS (Zenlabs Ethica Ltd)

Zenlabs Ethica Ltd is a multifaceted commercial enterprise operating in the diversified services sector. At its core, the company functions as a comprehensive solutions provider, a...ddressing a wide spectrum of needs for businesses across various industries. Their offerings encompass strategic consulting, operational optimization, and technological integration, each tailored to enhance efficiency and drive sustainable growth for their clientele. Zenlabs Ethica prides itself on a client-centric approach, fostering collaborative partnerships to deeply understand the unique challenges and objectives of each organization they serve. This dedication allows them to craft bespoke solutions that yield measurable results, solidifying their position as a trusted advisor and a catalyst for business transformation. Beyond its core consulting and optimization services, Zenlabs Ethica extends its capabilities to include specialized project management and implementation support. This end-to-end approach ensures seamless integration of new strategies and technologies, minimizing disruption and maximizing impact. Zenlabs Ethica invests significantly in research and development, continuously exploring emerging trends and technologies to stay at the forefront of innovation. This commitment allows them to provide clients with cutting-edge solutions that anticipate future challenges and opportunities. Their team of experienced professionals leverages deep industry knowledge and technical expertise to deliver exceptional value, consistently exceeding client expectations and forging long-term relationships built on trust and mutual success. Further distinguishing itself, Zenlabs Ethica incorporates a strong commitment to ethical business practices and social responsibility into its operational framework. This ethos guides their decision-making processes and fosters a culture of transparency and integrity. Their corporate social responsibility initiatives focus on community development, environmental sustainability, and the promotion of ethical governance. Zenlabs Ethica views its role not just as a service provider, but as a responsible corporate citizen contributing to the well-being of society. This commitment to ethical practices and social responsibility strengthens their brand reputation and fosters a positive impact on the communities they serve. Their dedication to excellence, innovation, and ethical conduct positions Zenlabs Ethica as a leader in the diversified commercial services industry.

Company Details

Symbol:ZENLABS
Industry:Diversified Commercial Services
Sector:Diversified Commercial Services

Key Leadership

Mr. Sanjeev Kumar Singal
Chairman of the Board, CEO & MD
Mr. Adarsh Sharma
Chief Financial Officer
Mr. Sanjay Dhir
Executive Whole Time Director

ZENLABS Share Price: Frequently Asked Questions

What is the current share price of Zenlabs Ethica Ltd?

Zenlabs Ethica Ltd (ZENLABS) trades at ₹28.83 on NSE and BSE. Market cap ₹20.67 (Cr). Educational data only.

What is the P/E ratio of Zenlabs Ethica Ltd?

Zenlabs Ethica Ltd has a P/E of 1033.48x vs industry average 19.79x.

What is the Bull Run score for Zenlabs Ethica Ltd?

Zenlabs Ethica Ltd has a Bull Run score of 4.6/100 based on 25+ financial parameters.

Does Zenlabs Ethica Ltd pay dividends?

Zenlabs Ethica Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.

What is the ROE of Zenlabs Ethica Ltd?

Zenlabs Ethica Ltd has ROE of 0.21%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Zenlabs Ethica Ltd?

Zenlabs Ethica Ltd has debt-to-equity of 1.29.

Is Zenlabs Ethica Ltd a good investment?

Bull Run gives Zenlabs Ethica Ltd a score of 4.6/100. This is not investment advice — consult a SEBI-registered advisor.